Advantages of Fast-Acting ADP Receptor Blockade in Ischemic Heart Disease
- 1 February 2003
- journal article
- editorial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (2) , 158-159
- https://doi.org/10.1161/01.atv.0000053387.06709.32
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Blockade of the Platelet P2Y 12 Receptor by AR-C69931MX Sustains Coronary Artery Recanalization and Improves the Myocardial Tissue Perfusion in a Canine Thrombosis ModelArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Functional Significance of Adenosine 5′-Diphosphate Receptor (P2Y 12 ) in Platelet Activation Initiated by Binding of von Willebrand Factor to Platelet GP Ibα Induced by Conditions of High Shear RateCirculation, 2002
- Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugsJournal of Clinical Investigation, 2001
- The C6‐2B glioma cell P2YAC receptor is pharmacologically and molecularly identical to the platelet P2Y12 receptorBritish Journal of Pharmacology, 2001
- P2Y12, a New Platelet ADP Receptor, Target of ClopidogrelBiochemical and Biophysical Research Communications, 2001
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor–null miceJournal of Clinical Investigation, 1999
- The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.Journal of Clinical Investigation, 1997
- Role of ADP and thromboxanes in human thrombus formation in ex vivo modelsPlatelets, 1997
- An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.Journal of Clinical Investigation, 1995